AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Yazdi K Pithavala

Yazdi K Pithavala

Pfizer Inc. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4384861
-
person_outline Yazdi K Pithavala's MOST POPULAR ARTICLES
1-) Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results Journal of Clinical Oncology 23 (24), 5474-5483, 2005
2-) Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with … Journal of clinical oncology 23 (24), 5464-5473, 2005
3-) Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study The Lancet 371 (9630), 2101-2108, 2008
4-) Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial The lancet oncology 14 (12), 1233-1242, 2013
5-) Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis The Journal of Clinical Pharmacology 53 (5), 491-504, 2013